Managing MS in a changing treatment landscape
Identifieur interne : 000229 ( France/Analysis ); précédent : 000228; suivant : 000230Managing MS in a changing treatment landscape
Auteurs : Martin Duddy [Royaume-Uni] ; Aiden Haghikia [Allemagne] ; Eleonora Cocco [Italie] ; Christian Eggers [Autriche] ; Jelena Drulovic [Serbie] ; Olga Carmona [Espagne] ; Helene Zéphir [France] ; Ralf Gold [Allemagne]Source :
- Journal of Neurology [ 0340-5354 ] ; 2011-05-01.
English descriptors
- KwdEn :
Abstract
Abstract: Increasing options are dictating the development of new algorithms to provide guidance in the treatment of people with multiple sclerosis (MS). There is a wealth of evidence on the safety and efficacy of interferon-beta and glatiramer acetate, which have been used in Europe and in the United States for more than 10 years. The spectrum of approved indications for these conventional disease modifying therapies includes the treatment of relapsing-remitting MS, secondary progressive MS, and the clinically isolated syndrome. Beyond these therapies we already have the recently introduced antibody natalizumab and, in some countries, the immunosuppressive agent mitoxantrone. Oral therapies are expected in the near future, with the sphingosin-1-phosphate receptor modulator fingolimod approved in the US and the EU and the purine nucleoside analogue cladribine in Australia and Russia. The evidence on all of these conventional and novel therapeutics is reviewed in this paper to provide an overview of the changing landscape of MS treatment.
Url:
DOI: 10.1007/s00415-011-6009-x
Affiliations:
- Allemagne, Autriche, Espagne, France, Italie, Royaume-Uni, Serbie
- Hauts-de-France, Nord-Pas-de-Calais
- Lille
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000F74
- to stream Istex, to step Curation: 000F41
- to stream Istex, to step Checkpoint: 000611
- to stream Main, to step Merge: 001646
- to stream Main, to step Curation: 001644
- to stream Main, to step Exploration: 001644
- to stream France, to step Extraction: 000229
Links to Exploration step
ISTEX:10C88A2682CE6DA5C5BC728AD251C0D141ADB786Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Managing MS in a changing treatment landscape</title><author><name sortKey="Duddy, Martin" sort="Duddy, Martin" uniqKey="Duddy M" first="Martin" last="Duddy">Martin Duddy</name></author><author><name sortKey="Haghikia, Aiden" sort="Haghikia, Aiden" uniqKey="Haghikia A" first="Aiden" last="Haghikia">Aiden Haghikia</name></author><author><name sortKey="Cocco, Eleonora" sort="Cocco, Eleonora" uniqKey="Cocco E" first="Eleonora" last="Cocco">Eleonora Cocco</name></author><author><name sortKey="Eggers, Christian" sort="Eggers, Christian" uniqKey="Eggers C" first="Christian" last="Eggers">Christian Eggers</name></author><author><name sortKey="Drulovic, Jelena" sort="Drulovic, Jelena" uniqKey="Drulovic J" first="Jelena" last="Drulovic">Jelena Drulovic</name></author><author><name sortKey="Carmona, Olga" sort="Carmona, Olga" uniqKey="Carmona O" first="Olga" last="Carmona">Olga Carmona</name></author><author><name sortKey="Zephir, Helene" sort="Zephir, Helene" uniqKey="Zephir H" first="Helene" last="Zéphir">Helene Zéphir</name></author><author><name sortKey="Gold, Ralf" sort="Gold, Ralf" uniqKey="Gold R" first="Ralf" last="Gold">Ralf Gold</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:10C88A2682CE6DA5C5BC728AD251C0D141ADB786</idno><date when="2011" year="2011">2011</date><idno type="doi">10.1007/s00415-011-6009-x</idno><idno type="url">https://api.istex.fr/ark:/67375/VQC-C4JT1MJL-D/fulltext.pdf</idno><idno type="wicri:Area/Istex/Corpus">000F74</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000F74</idno><idno type="wicri:Area/Istex/Curation">000F41</idno><idno type="wicri:Area/Istex/Checkpoint">000611</idno><idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">000611</idno><idno type="wicri:doubleKey">0340-5354:2011:Duddy M:managing:ms:in</idno><idno type="wicri:Area/Main/Merge">001646</idno><idno type="wicri:Area/Main/Curation">001644</idno><idno type="wicri:Area/Main/Exploration">001644</idno><idno type="wicri:Area/France/Extraction">000229</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Managing MS in a changing treatment landscape</title><author><name sortKey="Duddy, Martin" sort="Duddy, Martin" uniqKey="Duddy M" first="Martin" last="Duddy">Martin Duddy</name><affiliation wicri:level="1"><country xml:lang="fr">Royaume-Uni</country><wicri:regionArea>Department of Neurology, Royal Victoria Infirmary, Newcastle-upon-Tyne</wicri:regionArea><wicri:noRegion>Newcastle-upon-Tyne</wicri:noRegion></affiliation></author><author><name sortKey="Haghikia, Aiden" sort="Haghikia, Aiden" uniqKey="Haghikia A" first="Aiden" last="Haghikia">Aiden Haghikia</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, St. Josef-Hospital/Ruhr-University Bochum, Gudrunstrasse 56, 44791, Bochum</wicri:regionArea><wicri:noRegion>44791, Bochum</wicri:noRegion><wicri:noRegion>Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Cocco, Eleonora" sort="Cocco, Eleonora" uniqKey="Cocco E" first="Eleonora" last="Cocco">Eleonora Cocco</name><affiliation wicri:level="1"><country xml:lang="fr">Italie</country><wicri:regionArea>Multiple Sclerosis Centre, Department of Cardiovascular and Neurological Science, University of Cagliari, Cagliari</wicri:regionArea><wicri:noRegion>Cagliari</wicri:noRegion></affiliation></author><author><name sortKey="Eggers, Christian" sort="Eggers, Christian" uniqKey="Eggers C" first="Christian" last="Eggers">Christian Eggers</name><affiliation wicri:level="1"><country xml:lang="fr">Autriche</country><wicri:regionArea>Department of Neurology, Krankenhaus der Barmherzigen Brüder, Linz</wicri:regionArea><wicri:noRegion>Linz</wicri:noRegion></affiliation></author><author><name sortKey="Drulovic, Jelena" sort="Drulovic, Jelena" uniqKey="Drulovic J" first="Jelena" last="Drulovic">Jelena Drulovic</name><affiliation wicri:level="1"><country xml:lang="fr">Serbie</country><wicri:regionArea>Clinic of Neurology, Faculty of Medicine, University of Belgrade, Belgrade</wicri:regionArea><wicri:noRegion>Belgrade</wicri:noRegion></affiliation></author><author><name sortKey="Carmona, Olga" sort="Carmona, Olga" uniqKey="Carmona O" first="Olga" last="Carmona">Olga Carmona</name><affiliation wicri:level="1"><country xml:lang="fr">Espagne</country><wicri:regionArea>Neurology Department, Hospital de Figueres, Girona</wicri:regionArea><wicri:noRegion>Girona</wicri:noRegion></affiliation></author><author><name sortKey="Zephir, Helene" sort="Zephir, Helene" uniqKey="Zephir H" first="Helene" last="Zéphir">Helene Zéphir</name><affiliation wicri:level="3"><country xml:lang="fr">France</country><wicri:regionArea>Department of Neurology, Hôpital R. Salengro, Lille</wicri:regionArea><placeName><region type="region">Hauts-de-France</region><region type="old region">Nord-Pas-de-Calais</region><settlement type="city">Lille</settlement></placeName></affiliation></author><author><name sortKey="Gold, Ralf" sort="Gold, Ralf" uniqKey="Gold R" first="Ralf" last="Gold">Ralf Gold</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Department of Neurology, St. Josef-Hospital/Ruhr-University Bochum, Gudrunstrasse 56, 44791, Bochum</wicri:regionArea><wicri:noRegion>44791, Bochum</wicri:noRegion><wicri:noRegion>Bochum</wicri:noRegion></affiliation><affiliation wicri:level="1"><country wicri:rule="url">Allemagne</country></affiliation></author></analytic><monogr></monogr><series><title level="j">Journal of Neurology</title><title level="j" type="sub">Official Journal of the European Neurological Society</title><title level="j" type="abbrev">J Neurol</title><idno type="ISSN">0340-5354</idno><idno type="eISSN">1432-1459</idno><imprint><publisher>Springer-Verlag</publisher><pubPlace>Berlin/Heidelberg</pubPlace><date type="published" when="2011-05-01">2011-05-01</date><biblScope unit="volume">258</biblScope><biblScope unit="issue">5</biblScope><biblScope unit="page" from="728">728</biblScope><biblScope unit="page" to="739">739</biblScope></imprint><idno type="ISSN">0340-5354</idno></series></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0340-5354</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Cladribine</term><term>Fingolimod</term><term>Glatiramer acetate</term><term>Interferon-beta</term><term>Mitoxantrone</term><term>Multiple sclerosis</term><term>Natalizumab</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Abstract: Increasing options are dictating the development of new algorithms to provide guidance in the treatment of people with multiple sclerosis (MS). There is a wealth of evidence on the safety and efficacy of interferon-beta and glatiramer acetate, which have been used in Europe and in the United States for more than 10 years. The spectrum of approved indications for these conventional disease modifying therapies includes the treatment of relapsing-remitting MS, secondary progressive MS, and the clinically isolated syndrome. Beyond these therapies we already have the recently introduced antibody natalizumab and, in some countries, the immunosuppressive agent mitoxantrone. Oral therapies are expected in the near future, with the sphingosin-1-phosphate receptor modulator fingolimod approved in the US and the EU and the purine nucleoside analogue cladribine in Australia and Russia. The evidence on all of these conventional and novel therapeutics is reviewed in this paper to provide an overview of the changing landscape of MS treatment.</div></front></TEI><affiliations><list><country><li>Allemagne</li><li>Autriche</li><li>Espagne</li><li>France</li><li>Italie</li><li>Royaume-Uni</li><li>Serbie</li></country><region><li>Hauts-de-France</li><li>Nord-Pas-de-Calais</li></region><settlement><li>Lille</li></settlement></list><tree><country name="Royaume-Uni"><noRegion><name sortKey="Duddy, Martin" sort="Duddy, Martin" uniqKey="Duddy M" first="Martin" last="Duddy">Martin Duddy</name></noRegion></country><country name="Allemagne"><noRegion><name sortKey="Haghikia, Aiden" sort="Haghikia, Aiden" uniqKey="Haghikia A" first="Aiden" last="Haghikia">Aiden Haghikia</name></noRegion><name sortKey="Gold, Ralf" sort="Gold, Ralf" uniqKey="Gold R" first="Ralf" last="Gold">Ralf Gold</name><name sortKey="Gold, Ralf" sort="Gold, Ralf" uniqKey="Gold R" first="Ralf" last="Gold">Ralf Gold</name></country><country name="Italie"><noRegion><name sortKey="Cocco, Eleonora" sort="Cocco, Eleonora" uniqKey="Cocco E" first="Eleonora" last="Cocco">Eleonora Cocco</name></noRegion></country><country name="Autriche"><noRegion><name sortKey="Eggers, Christian" sort="Eggers, Christian" uniqKey="Eggers C" first="Christian" last="Eggers">Christian Eggers</name></noRegion></country><country name="Serbie"><noRegion><name sortKey="Drulovic, Jelena" sort="Drulovic, Jelena" uniqKey="Drulovic J" first="Jelena" last="Drulovic">Jelena Drulovic</name></noRegion></country><country name="Espagne"><noRegion><name sortKey="Carmona, Olga" sort="Carmona, Olga" uniqKey="Carmona O" first="Olga" last="Carmona">Olga Carmona</name></noRegion></country><country name="France"><region name="Hauts-de-France"><name sortKey="Zephir, Helene" sort="Zephir, Helene" uniqKey="Zephir H" first="Helene" last="Zéphir">Helene Zéphir</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/StressCovidV1/Data/France/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000229 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/France/Analysis/biblio.hfd -nk 000229 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= StressCovidV1
|flux= France
|étape= Analysis
|type= RBID
|clé= ISTEX:10C88A2682CE6DA5C5BC728AD251C0D141ADB786
|texte= Managing MS in a changing treatment landscape
}}
| This area was generated with Dilib version V0.6.33. |  |